Nicolai Tangen’s AKO Capital Is Investing In These 5 Stocks

4. Thermo Fisher Scientific Inc. (NYSE:TMO)

AKO Capital’s Stake Value: $652.7 million
Percentage of AKO Capital’s 13F Portfolio: 6.76%
Number of Hedge Fund Holders: 87

Thermo Fisher Scientific Inc. (NYSE:TMO) is a Massachusetts-based provider of scientific instrumentation, reagents, consumables, and software services. The company recently acquired PPD, Inc., a leading global provider of clinical research, in a $17.4 billion total cash purchase deal.

On October 28, SVB Leerink analyst Puneet Souda maintained an Outperform rating on Thermo Fisher Scientific Inc. (NYSE:TMO) stock and raised the price target to $685 from $675.

AKO Capital currently holds over 1.14 million shares of Thermo Fisher Scientific Inc. (NYSE:TMO). These shares amount to more than $576.6 million and represent 6.76% of the investment firm’s total portfolio value. Of the 873 elite funds being tracked by Insider Monkey, 87 held stakes in the company at the end of the second quarter of 2021, worth $7.39 billion.

Out of the hedge funds in our database, Ken Fisher’s Fisher Asset Management is the biggest stakeholder in Thermo Fisher Scientific Inc. (NYSE:TMO), with 2.01 million shares worth approximately $1.14 billion.

In its Q2 2021 investor letter, ClearBridge Investments mentioned Thermo Fisher Scientific Inc. (NYSE:TMO). Here is what they said:

“Two additional names in the health care sector in the quarter, partially funded with a sale, made strong contributions and helped push our relative exposure to the sector from underweight to overweight. We added Thermo Fisher Scientific to increase our exposure to health care tools, which has been an attractive and core segment within health care. Thermo Fisher’s instruments are used to monitor and protect air, water, and food quality, and the company has strong long-term fundamentals, a top-tier management team and a diversified business.”